Intellectual Property Protection
Intellectual Property Protection
An Interactive Timeline of Akrolimb's Legal Strategy
A Timeline of Akrolimb's Legal Strategy
A Timeline of Akrolimb's Legal Strategy
2025
Copyright Registration
Secure copyright registration (India, UK, US) for software, UI/UX, and AI models to protect trade secrets
Freelance Logo Gig
Landed first paying design job, creating a memorable logo for a local business.
Adobe Creative Cloud Mastery
Mastered Illustrator, InDesign, and expanded skills with various Adobe tools.
National Design Competition Win
Clinched first place in a prestigious design competition, boosting confidence.
2026
First Design Job
Secured a junior designer position at a dynamic startup, diving into professional projects.
2027
Design Team Lead Promotion
Recognized for leadership qualities and promoted to lead a small design team.
Side Hustle Success
Launched a successful design-focused side business, balancing passion and profit.
2028+
Global Expansion & Enforcement
Launch full-scale international licensing & IP enforcement strategy. Strengthen patent portfolio, explore new markets, and ensure legal compliance in additional jurisdictions.
Patents - Protecting Innovation
In-Progress
Securing Akrolimb’s AI-driven prosthetic design and 3D scanning tech, ensuring exclusivity and preventing replication.
Copyrights – Securing Digital Assets
Completed
Software, AI models, and designs are automatically protected under copyright law, preventing unauthourised use.
Trade Secrets & Licensing – Legal Defensibility
Completed
Confidential algorithms and workflows are protected through strict NDAs and controlled licensing agreements.
Certification & Compliance
India
Akrolimb prosthetics are classified as Class A medical devices under the Medical Devices Rules, 2017 (India), ensuring fast-track approval and distribution.
India
Akrolimb prosthetics are classified as Class A medical devices under the Medical Devices Rules, 2017 (India), ensuring fast-track approval and distribution.
India
Akrolimb prosthetics are classified as Class A medical devices under the Medical Devices Rules, 2017 (India), ensuring fast-track approval and distribution.
India
Akrolimb prosthetics are classified as Class A medical devices under the Medical Devices Rules, 2017 (India), ensuring fast-track approval and distribution.
European Union
Akrolimb is working towards CE Marking under Medical Devices Regulation (MDR) 2017/745, allowing market entry into the European healthcare system.
European Union
Akrolimb is working towards CE Marking under Medical Devices Regulation (MDR) 2017/745, allowing market entry into the European healthcare system.
European Union
Akrolimb is working towards CE Marking under Medical Devices Regulation (MDR) 2017/745, allowing market entry into the European healthcare system.
European Union
Akrolimb is working towards CE Marking under Medical Devices Regulation (MDR) 2017/745, allowing market entry into the European healthcare system.
United States of America
To enter the US market, Akrolimb is pursuing FDA 510(k) clearance under 21 CFR Part 807, demonstrating substantial equivalence to existing prosthetics.
United States of America
To enter the US market, Akrolimb is pursuing FDA 510(k) clearance under 21 CFR Part 807, demonstrating substantial equivalence to existing prosthetics.
United States of America
To enter the US market, Akrolimb is pursuing FDA 510(k) clearance under 21 CFR Part 807, demonstrating substantial equivalence to existing prosthetics.
United States of America
To enter the US market, Akrolimb is pursuing FDA 510(k) clearance under 21 CFR Part 807, demonstrating substantial equivalence to existing prosthetics.
Legal Risk Mitigation FAQ
Legal Risk Mitigation FAQ
01
How does Akrolimb prevent competitors from patenting similar innovations?
02
What actions does Akrolimb take against IP theft and unauthorized use of its technology?
03
How does Akrolimb secure its trade secrets, such as AI models and scanning algorithms?
04
How does Akrolimb ensure its prosthetics comply with medical device regulations globally?
05
What steps has Akrolimb taken to mitigate risks in obtaining regulatory approval?
06
How does Akrolimb manage clinical testing risks for its prosthetics?
07
How does Akrolimb ensure the security of patient data collected through its scanning technology?
01
How does Akrolimb prevent competitors from patenting similar innovations?
02
What actions does Akrolimb take against IP theft and unauthorized use of its technology?
03
How does Akrolimb secure its trade secrets, such as AI models and scanning algorithms?
04
How does Akrolimb ensure its prosthetics comply with medical device regulations globally?
05
What steps has Akrolimb taken to mitigate risks in obtaining regulatory approval?
06
How does Akrolimb manage clinical testing risks for its prosthetics?
07
How does Akrolimb ensure the security of patient data collected through its scanning technology?
01
How does Akrolimb prevent competitors from patenting similar innovations?
02
What actions does Akrolimb take against IP theft and unauthorized use of its technology?
03
How does Akrolimb secure its trade secrets, such as AI models and scanning algorithms?
04
How does Akrolimb ensure its prosthetics comply with medical device regulations globally?
05
What steps has Akrolimb taken to mitigate risks in obtaining regulatory approval?
06
How does Akrolimb manage clinical testing risks for its prosthetics?
07
How does Akrolimb ensure the security of patient data collected through its scanning technology?
01
How does Akrolimb prevent competitors from patenting similar innovations?
02
What actions does Akrolimb take against IP theft and unauthorized use of its technology?
03
How does Akrolimb secure its trade secrets, such as AI models and scanning algorithms?
04
How does Akrolimb ensure its prosthetics comply with medical device regulations globally?
05
What steps has Akrolimb taken to mitigate risks in obtaining regulatory approval?
06
How does Akrolimb manage clinical testing risks for its prosthetics?
07
How does Akrolimb ensure the security of patient data collected through its scanning technology?